hbsag loss: a predictor of long-term clinical outcomes - m. peters, md
Published 2 years ago • 550 plays • Length 15:03Download video MP4
Download video MP3
Similar videos
-
18:39
what are the pros and cons of hbsag loss as the endpoint for treatment? | jordan feld, md, mph
-
16:10
will hbsag depletion restore hbv specific immunity? | adam gehring, phd
-
27:21
personalized approaches to hbv cure | marion peters, md
-
16:23
study design with new combinations - marion peters
-
8:34
immunotherapeutics in the treatment of chronic hepatitis b - s. browne, md
-
28:56
what’s new in hepatitis b treatment & diagnostics | seng gee lim, mbbs, fracp, frcp, md
-
9:04
hepatitis b prevention | 8 food to cure hepatitis b | nourish nest
-
1:42
how does hepatitis b make you feel? hepatitis b symptoms
-
5:04
best antiviral medicines for treatment of hepatitis b | great wisdom discover
-
10:30
understanding hepatitis b serology results
-
23:11
hbv: diagnostics, management and screening | marion peters, md
-
13:29
outcomes after nuc therapy discontinuation - m. cornberg, md
-
26:51
the abc of viral hepatitis | mark thursz, mrcp
-
24:23
new treatment strategies for hepatitis b | harry janssen, md, phd
-
3:30
the truth about hepatitis b
-
7:03
hepatitis b: explained
-
39:45
round table discussion: trial design, treatment endpoints and regulatory approach
-
16:53
how to combine new treatments? clinical approach | marion peters, md
-
6:47
how to reduce hepatitis b viral load naturally | how to reduce hepatitis b
-
0:19
hepatitis b everything you need to know | #mcashorts
-
11:25
stop agents - m. mcclure, md